258
Views
0
CrossRef citations to date
0
Altmetric
Letter

Identification of apolipoprotein A-I as a target of platelet tyrosine kinases

, , &
Article: 2290921 | Received 23 Dec 2022, Accepted 30 Nov 2023, Published online: 15 Dec 2023

References

  • Mineo C, Shaul PW. Regulation of signal transduction by hdl. J Lipid Res. 2013;54(9):2315–3. doi:10.1194/jlr.R039479.
  • Bhale AS, Venkataraman K. Leveraging knowledge of HDLs major protein apoa1: structure, function, mutations, and potential therapeutics. Biomed Pharmacother. 2022;154:113634. doi:10.1016/j.biopha.2022.113634.
  • Jones WL, Ramos CR, Banerjee A, Moore EE, Hansen KC, Coleman JR, Kelher M, Neeves KB, Silliman CC, Di Paola J, et al. Apolipoprotein a-i, elevated in trauma patients, inhibits platelet activation and decreases clot strength. Platelets. 2022;33(8):1–13. doi:10.1080/09537104.2022.2078488.
  • Faria AVS, Andrade SS, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM. The role of phospho-tyrosine signaling in platelet biology and hemostasis. Biochim Biophys Acta Mol Cell Res. 2021;1868(3):118927. doi:10.1016/j.bbamcr.2020.118927.
  • Ferrell JE Jr., Martin GS. Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Mol Cell Biol. 1988;8(9):3603–10. doi:10.1128/MCB.8.9.3603.
  • Fälker K, Lange D, Presek P. P2y12 adp receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kda in thrombin-stimulated human platelets. Thromb Haemost. 2005;93(5):880–8. doi:10.1160/TH04-09-0612.
  • Timm T, Annoscia G, Klein J, Lochnit G. The eukaryotic elongation factor 1 alpha (eEF1alpha) from the parasite leishmania infantum is modified with the immunomodulatory substituent Phosphorylcholine (PC). Molecules. 2017;22(12):2094. doi:10.3390/molecules22122094.
  • Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 2003;31(13):3635–3641. doi:10.1093/nar/gkg584.
  • Briddon SJ, Watson SP. Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets. Biochem J. 1999;338(Pt 1):203–209. doi:10.1042/bj3380203.
  • Hughan SC, Hughes CE, McCarty OJ, Schweighoffer E, Soultanova I, Ware J, Tybulewicz VL, Watson SP. Gpvi potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and syk. Arterioscler Thromb Vasc Biol. 2007;27(2):422–9. doi:10.1161/01.ATV.0000252826.96134.21.
  • Gratacap MP, Martin V, Valera MC, Allart S, Garcia C, Sie P, Recher C, Payrastre B. The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo. Blood. 2009;114(9):1884–92. doi:10.1182/blood-2009-02-205328.
  • Mei X, Atkinson D. Crystal structure of c-terminal truncated apolipoprotein a-i reveals the assembly of high density lipoprotein (hdl) by dimerization. J Biol Chem. 2011;286(44):38570–82. doi:10.1074/jbc.M111.260422.
  • Komatsuya K, Kaneko K, Kasahara K. Function of platelet glycosphingolipid microdomains/lipid rafts. Int J Mol Sci. 2020;21(15):5539. doi:10.3390/ijms21155539.
  • Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103(6):2096–104. doi:10.1182/blood-2003-08-2804.
  • Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73–82. doi:10.1182/blood-2012-04-416594.